Nikkei BP article about IMPUTE’s efforts and its goal for autism treatment. column/19/102700113/

The Latest news

Impute recently raised a pre-series A round from TEP (Tx Entrepreneurs Partners), Arco Partners and other angel investors.

Impute has signed an Joint Research and development program with National Centre for Child Health and Development for ASD digital therapeutic app.